Guyana - Re-Export of Penicillins or Streptomycins Not in Dosage Forms

Since 2011, Guyana Re-Export of Penicillins or Streptomycins Not in Dosage Forms grew 152% year on year. In 2016, the country was ranked number 6 among other countries in Re-Export of Penicillins or Streptomycins Not in Dosage Forms at $7,014. Guyana is overtaken by Yemen, which was number 5 with $26,317 and is followed by Namibia at $6,788.77. New Zealand lead the ranking with $476,039.52 in 2019, that is a fall of 2.3% compared to 2018. United States, Saudi Arabia and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. Guyana recorded the best 5 years average growth at +152% per year, while United States was the worst growing country at -25.7% per year.

Loading...

Date US Dollars
2016 7,014.00
2015 43.44
2014 5,638.00
2013
2012
Download all data from 2001 to 2016

How does Guyana rank in Re-Export of Penicillins or Streptomycins Not in Dosage Forms?

# 11 Countries US Dollars Last YoY 5‑years CAGR
1 #1
New Zealand
476,039.52 2019 -2.3 % -7.7 % View data
2 #2
United States
108,118.00 2019 -33.5 % -25.7 % View data
5 #5
Yemen
26,317.00 2015 +2,726.8 % NA View data
6 #6
Guyana
7,014.00 2016 +16,047.1 % +152.0 % View data
7 #7
Namibia
6,788.77 2017 +151.1 % NA View data
Compare all 11 countries

Go Top